Piperitone is a minty monoterpene ketone found in several essential-oil chemotypes, including peppermint eucalyptus and other piperitone-rich aromatic materials represented in the AromaForge archive. Compared with many minor terpenes, it has a moderate direct literature trail: identity and flavor-use data are strong, while bioactivity evidence comes mainly from recent preclinical antifungal and insect-repellent studies rather than human trials. AromaForge should present piperitone as an aroma-active ketone with meaningful laboratory-stage mechanism data and a limited but real flavor-safety record, not as a clinically established wellness ingredient.
Aroma and practical use
- Use the recorded minty, herbal, camphoraceous, fresh, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2024 Food Microbiology study found that piperitone significantly inhibited Aspergillus flavus growth, reduced aflatoxin B1 production, and lowered pathogenicity on peanuts and corn flour.
A 2024 Food Microbiology study found that piperitone significantly inhibited Aspergillus flavus growth, reduced aflatoxin B1 production, and lowered pathogenicity on peanuts and corn flour.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2023 avocado-grove field study reported that piperitone and verbenone produced comparable repellency against Euwallacea perbrevis, reducing trap captures by about 50-70% over 10-12 weeks.
A 2023 avocado-grove field study reported that piperitone and verbenone produced comparable repellency against Euwallacea perbrevis, reducing trap captures by about 50-70% over 10-12 weeks.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A second 2023 field study reported that adding piperitone to alpha-copaene-baited traps reduced captures of Xyleborus glabratus by 68-90%, with activity persisting across the full 10-week test period.
A second 2023 field study reported that adding piperitone to alpha-copaene-baited traps reduced captures of Xyleborus glabratus by 68-90%, with activity persisting across the full 10-week test period.
This experimental finding does not establish benefit, dose or safety in people using this blend.
WHO/JECFA records for piperitone state 'no safety concern at current levels of intake when used as a flavouring agent,' which is useful food-flavor safety context but does not establish topical or inhalation safety for isolated aromatherapy use.
WHO/JECFA records for piperitone state 'no safety concern at current levels of intake when used as a flavouring agent,' which is useful food-flavor safety context but does not establish topical or inhalation safety for isolated aromatherapy use.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedWHO/JECFA lists piperitone as presenting no safety concern at current levels of intake when used as a flavoring agent.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
The reviewed public safety framing is mainly for flavor use; no constituent-specific human dermal limit or inhalation tolerability study was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
fungal_cell_wall_and_membrane_disruption
In Aspergillus flavus, piperitone down-regulated genes tied to chitin, glucan, and ergosterol synthesis and reduced ergosterol content, consistent with impaired cell-wall and cell-membrane integrity.
This experimental finding does not establish benefit, dose or safety in people using this blend.
ros_accumulation_and_aflatoxin_pathway_suppression
The same study reported reduced antioxidant-enzyme activity, increased reactive oxygen species, DNA fragmentation, autophagy, and down-regulation of 16 aflatoxin-cluster genes.
This experimental finding does not establish benefit, dose or safety in people using this blend.
olfactory_repellency_signal
Electroantennography in ambrosia beetles showed measurable olfactory response to piperitone, supporting a semiochemical repellent mechanism in pest-management studies.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical efficacy evidence for isolated piperitone was verified.
- The strongest direct mechanism data are antifungal and agricultural rather than wellness-oriented.
- Public constituent-specific dermal and inhalation safety data remain limited.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.